Autocyte PREP

Autocyte PREP®

A monolayer slide preparation and discrete-staining lab product used for cytologic specimens (e.g., Pap smears).

Autocyte PREP®

Cytology A monolayer slide preparation and discrete-staining lab product used for cytologic specimens–eg, Pap smears. See Pap smear.
References in periodicals archive ?
Earlier this year he relinquished his European export director's role with CellPath to concentrate on developing the company's sales of the AutoCyte PREP liquid based cytology system in the UK and Ireland for United States manufacturers TriPath Imaging.
The company produces the AutoCyte PREP system, which aims to speed the process of analysing smear tests Mrs Betts, 37, aims to put six years of experience as a cytoscreener at Llandough Hospital to good use.
Burlington, NC, has received FDA approval to include the screening of AutoCyte Prep thin-layer slide preparations on the AutoPap Primary Screening System.
Nasdaq: TPTH) ("TriPath Imaging" or "the Company") today reported that domestic sales of AutoCyte PREP ("PREP") related reagents and disposables increased approximately 20% and the rate of placement of new PREP Systems increased over 30% from the prior quarter.
The companies will work together to develop clinical trials in support of a supplement to NeoPath's current PMA approval which would allow the AutoPap Primary Screening System to also screen the newer AutoCyte PREP slides.
We are confident that our customers will realize the clinical and economic benefits of screening of AutoCyte PREP slides on the AutoPap Primary Screening System.
Managing director Terry Hammett will run CellPath's sales team, while Adrian Jackson relinquishes his European export director's role to concentrate on developing sales of the company's AutoCyte PREP liquid-based cytology system in the UK and Republic of Ireland.
recently announced that the FDA has approved the PREPmate, an accessory to the AutoCyte [R] PREP System and the manual method for preparation of AutoCyte Prep thin-layer slides for cytologic screening for uterine cervical cancer.
A similar study reported in the Journal of Reproductive Medicine (45:1-16) showed a 157% increase in HSIL detection over traditional methods using the company's AutoCyte PREP method, which is performed on the AutoPap system.
Sohmer commented, "We are pleased with the continued growth of our AutoCyte PREP products.
Food and Drug Administration (FDA) has approved the PREPmate, an accessory to the AutoCyte(R) PREP System ("AutoCyte PREP"), and the manual method for preparation of AutoCyte PREP thin-layer slides for cytologic screening for cancer of the uterine cervix.